IL324481A - תכשירים והכנה של שלפוחית חוץ תאית - Google Patents

תכשירים והכנה של שלפוחית חוץ תאית

Info

Publication number
IL324481A
IL324481A IL324481A IL32448125A IL324481A IL 324481 A IL324481 A IL 324481A IL 324481 A IL324481 A IL 324481A IL 32448125 A IL32448125 A IL 32448125A IL 324481 A IL324481 A IL 324481A
Authority
IL
Israel
Prior art keywords
ref
composition
extracellular vesicles
milk
tryptophan
Prior art date
Application number
IL324481A
Other languages
English (en)
Original Assignee
Virginia Tech Intellectual Properties Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virginia Tech Intellectual Properties Inc filed Critical Virginia Tech Intellectual Properties Inc
Publication of IL324481A publication Critical patent/IL324481A/he

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/5176Compounds of unknown constitution, e.g. material from plants or animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1276Globules of milk; Constituents thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Botany (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IL324481A 2023-05-09 2024-05-09 תכשירים והכנה של שלפוחית חוץ תאית IL324481A (he)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202363465073P 2023-05-09 2023-05-09
US202463624637P 2024-01-24 2024-01-24
US202463640825P 2024-04-30 2024-04-30
PCT/US2024/028635 WO2024233809A2 (en) 2023-05-09 2024-05-09 Extracellular vesicle compositions and preparation

Publications (1)

Publication Number Publication Date
IL324481A true IL324481A (he) 2026-01-01

Family

ID=93431226

Family Applications (1)

Application Number Title Priority Date Filing Date
IL324481A IL324481A (he) 2023-05-09 2024-05-09 תכשירים והכנה של שלפוחית חוץ תאית

Country Status (6)

Country Link
EP (1) EP4709357A2 (he)
KR (1) KR20260003368A (he)
CN (1) CN121335693A (he)
AU (1) AU2024269259A1 (he)
IL (1) IL324481A (he)
WO (1) WO2024233809A2 (he)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022170176A1 (en) * 2021-02-05 2022-08-11 The Trustees Of Columbia University In The City Of New York Enhanced delivery vehicle for a treating agent
JP2024528708A (ja) * 2021-07-21 2024-07-30 パーデュー リサーチ ファウンデーション がん免疫療法を増強するための免疫原性細胞死誘導剤のナノ構築物及びナノ粒子媒介性送達

Also Published As

Publication number Publication date
AU2024269259A1 (en) 2025-12-04
CN121335693A (zh) 2026-01-13
WO2024233809A3 (en) 2025-03-27
WO2024233809A2 (en) 2024-11-14
EP4709357A2 (en) 2026-03-18
KR20260003368A (ko) 2026-01-06

Similar Documents

Publication Publication Date Title
US20260014085A1 (en) Milk derived exosomes and uses thereof
EP2628484B9 (en) Platelet-rich plasma compositions
AU2011331901B2 (en) Anti-inflammatory compositions
US20230313191A1 (en) Rna comprising secretomes and methods of their use
US11603394B2 (en) Targeted effector proteins and uses thereof
RS62244B1 (sr) Tatk-cdkl5 fuzioni proteini, sastavi, formulacije i njihova upotreba
KR102415978B1 (ko) 레반-단백질 나노복합체 및 이의 용도
US20240226809A9 (en) Methods of isolating exosomes
KR100939983B1 (ko) 히아루론산-소수성 폴리 아미노산 공중합체
WO2024233809A2 (en) Extracellular vesicle compositions and preparation
HK40130277A (zh) 细胞外囊泡组合物和制备
JP6247687B2 (ja) 疎水性タンパク質の新規放出システム
JPWO2010058517A1 (ja) IgGおよび/またはIgGのFc断片を含む神経細胞刺激剤
HK40103176A (zh) 分离外泌体的方法
KR20250144089A (ko) 밀크 엑소좀을 유효성분으로 포함하는 키 성장 촉진용 조성물
EP1581623A2 (en) Trefoil domain-containing polypeptides and uses thereof
EP4714496A2 (en) Treatment of neuronal ceroid lipofuscinosis
EP4622653A1 (en) Compositions based on a mixture of bioactive molecules and exosomes for use in the treatment of conditions requiring tissue repair and regeneration
JP2017530189A (ja) 低分子量ペプチド又はタンパク質のナノ沈殿物を調製する方法
KR20170041116A (ko) 신경계의 보호 및/또는 복구용 조성물 및 방법